Complementary DNA (cDNA) specific for gamma-globin nucleotide sequences has been prepared by hybridizing total cDNA made from cord blood messenger RNA (mRNA) as template to an excess of normal adult human globin mRNA and recovering the singlestranded cDNA from hydroxylapatite. The specificity of the gamma cDNA for gamma mRNA sequences is strongly supported by the hybridization of this cDNA at low Cot values (Co, concentration of RNA and t, time in seconds) to RNA samples containing large amounts of functional gamma globin mRNA and the lack of hybridization to RNA samples containing little, if any, gamma-globin mRNA. The absence of cross-hybridization of gamma cDNA with alpha, beta, and delta mRNAs is demonstrated by the complete hybridization of the gamma cDNA to mRNA samples completely lacking either alpha or beta and delta mRNA. An estimate of the number of gamma-globin genes in human cellular DNA was obtained by hybridization of purified gamma cDNA to DNA from spleen and white blood cells of normal and beta-thalassemia subjects and measurement of the percent of gamma cDNA hybridized at saturation. The results indicate that there are between one and two gamma-globin genes per total haploid gene DNA equivalent obtained from both normal and beta-thalassemia subjects. These values are consistent with genetic evidence for the presence of multiple gamma gene loci in human cells. The 
A B S T R A C T Complementary DNA (cDNA) specific for y-globin nucleotide sequences has been prepared by hybridizing total cDNA made from cord blood messenger RNA (mRNA) as template to an excess of normal adult human globin mRNA and recovering the single-stranded cDNA from hydroxylapatite. The specificity of the y cDNA for y mRNA sequences is strongly supported by the hybridization ofthis cDNA at low Cjt values (CO, concentration of RNA and t, time in seconds) to RNA samples containing large amounts of functional y globin mRNA and the lack of hybridization to RNA samples containing little, if any, y-globin mRNA. The absence of cross-hybridization of y cDNA with a, f3, and 8 mRNAs is demonstrated by the complete hybridization of the y cDNA to mRNA samples completely lacking either a or (3 and 8 mRNA. An estimate of the number of y-globin genes in human cellular DNA was obtained by hybridization of purified y cDNA to DNA from spleen and white blood cells of normal and (8-thalassemia subjects and measurement of the percent of y cDNA hybridized at saturation. The results indicate that there are between one and two y-globin genes per total haploid gene DNA equivalent obtained from both normal and ,8-thalassemia subjects. These values are consistent with genetic evidence for the presence of multiple y gene loci in human cells. The finding that the number of y-globin genes in (8-thalassemia DNA is similar to that in nonthalassemia DNA indicates that a deletion of y-globin genes cannot account for either INTRODUCTION The use of highly radioactive complementary DNA (cDNA)1 has recently permitted the measurement of the number of globin genes in a variety of mammalian species (1) (2) (3) . In addition, purified a and (8 cDNAs from human cells have been used to quantitate the relative number of a-and (8-globin genes in human DNA (4, 5) . The results indicate that there are between one and four a-globin genes, and one and five , 8-globin genes per haploid human genome. More recently, the specificity of the hybridization of purified a and (3 cDNA probes to complementary nucleotide sequences in human cellular DNA has been strengthened by the detection of deletions of a-and (3-like globin genes in certain forms of a-and (3-thalassemia (4, (6) (7) (8) and in hereditary persistance of fetal hemoglobin (8) (9) (10) . To quantitate the number of y-globin genes in human cells, we have prepared specific y-globin cDNA by hybridizing the cDNA synthesized with cord blood messenger RNA (mRNA) as substrate (a, (3, 
METHODS
Human globin mRNAs were obtained by extraction of either peripheral blood or liver of a patient with hydrops fetalis as described previously (4). The 6-16S RNA region was routinely isolated for use in the preparation of globin cDNA and for hybridization to purified and total cDNA. a and (8 cDNA were purified as previously reported (4) . Globin synthesis in intact cells and translation of globin mRNA in a Krebs ascites tumor cell-free system was as previously described (11) .
Preparation of y-globin cDNA. The preparation of yglobin cDNA was analogous to that described previously (12) . In our experiments, 10ug of cord blood mRNA was used as template for the production of a-, (8- (4) , while the single-stranded material was used as y-globin cDNA. The y cDNA migrated as a single homogeneous peak of 7S DNA on alkaline sucrose gradients (13) and contained approximately 500 nucleotides when analyzed by polyacrylamide gel electrophoresis in formamide (14) . Preparation of human DNA. DNA was prepared from human spleen and liver of patients with and without (8-thalassemia, as described previously (3, 4) . DNA from peripheral blood was prepared similarly, except that the blood sample containing white blood cells was washed three times with 10 vol of isotonic saline, frozen, and thawed before washing with 5% sucrose containing 1 mM MgCl2, 1 mM sodium phosphate (pH 6.5), 0.4% deoxycholate, and 0.8% Nonidet P40 (Shell International Ltd., London, England).
Hybridization of cDNA with human mRNA and cellular DNA. Globin cDNA was hybridized with mRNA under conditions described previously (15) and for 4 h unless otherwise specified. With this methodology, it has been shown previously (16) that the relative Cot 1/2 values obtained (Table I) are proportional to the amount of mRNA present over a wide range of RNA concentrations. Globin mRNA was prepared by isolating 6-16S RNA from sucrose density gradients unless otherwise indicated (13) . Hybridization of globin cDNA with spleen, liver, or white cell DNA was also previously described (4, 5) .
RESULTS
Properties of cord blood cDNA. The hybridization kinetics of total cord blood cDNA to cord blood mRNA and normal adult reticulocyte globin mRNA is shown in Fig. 1 . When cord blood cDNA and cord blood mRNA are annealed, a monophasic hybridization curve is obtained, indicating that the relative proportions of the different nucleotide sequences (a, 13, and y) are similar in both mRNA and cDNA. A similar monophasic curve is obtained when normal reticulocyte mRNA is hybridized with total cDNA prepared from normal adult reticulocyte mRNA (4) . By contrast, when cord blood cDNA is annealed to normal reticulocyte mRNA containing predominantly a and ,3 mRNA, the hybridization curve is diphasic (Fig. 1) . The initial hybridization to 65% is due to the re-annealing of a and (8 complementary sequences. Only after an additional 50-100-fold excess of normal mRNA is added is the remaining cDNA hybridized. This is presumably due to the small amount ofy mRNA present in normal reticulocyte mRNA, which requires that a large excess of this mRNA be added to hybridize the y cDNA of the cord blood cDNA. Presumed y cDNA was isolated from the total cord blood cDNA by separating hybridized and unhybridized cDNA at a Cot of 0.25 ( Quantitation of Human Gamma Globin Genes and Gamma Globin mRNA Hydrops fetalis (Fig. 3 )
Cord 1loo0( (Fig. 5a) 1 (Fig. 4 (Fig. 4, Table I ). In these experiments, it is also clear that the amount of y cDNA present in the cells measured by comparing hybridization to a, ,3, and y cDNA is comparable to the relative amounts of y-, ,a-, and a-globin synthesized by these cells or by mRNA isolated from them and translated in cell-free systems. In addition, with the mRNA of five patients with ,B0-thalassemia from Ferrara described elsewhere (8) Globin mRNA from reticulocytes of fetuses at birth (cord blood) was hybridized to purified a, /3, and y cDNAs (Table I, Fig. 5a ). When cord blood mRNA is hybridized to a, ,B, and y cDNA, the Cot 1/2 with a, /, and y mRNA are similar (Fig. 5a , Table I (Fig. 5b) Number of -globin genes in human DNA. We have previously reported that the relative numbers of aand /8-globin genes in normal DNA (4) . In these hybridizations with relative cDNA excess (see Table II , legend), a competition between the cDNA and one of the cellular DNA strands for the complementary cellular DNA strand limits the extent of cDNA hybridization (Fig. 6 , Table II) (3). By contrast, in vast cellular DNA excess, over 80%o of the y cDNA is hybridized. At inputs of cDNA per cellular DNA of 3.3 x 10-7 (relative cDNA excess), the hybridization of normal and thalassemia DNA to y cDNA was measured (Fig. 6, Table II ). At saturation hybridization with these inputs, approximately 40%o of the 'y cDNA was hybridized. When DNA from patients with /8-thalassemia is hybridized to y cDNA, results similar to those with DNA from normal cells are obtained (Fig. 6 , Table II ). The Cot 1/2 of the unique sequences in unlabelled cellular DNA in these studies is approximately 1,100, while that of the y cDNA was between 350 and 450 (Fig. 6 ). These data indicate no detectable deletion of y-globin genes in ,8-thalassemia of either the /83 or,/3 type in the patients studied.
DISCUSSION
We have previously separated a and /8 cDNA from total normal adult human cDNA by using mRNA from patients with hydrops fetalis that completely lacks a mRNA sequences. More recently, we have separated a and /3 mRNAs by acrylamide gel electrophoresis and have prepared a and , / cDNA using these mRNAs.2 2 Nudel, U., F. Ramirez, and A. Bank. In preparation.
The hybridization kinetics of the a and /8 eDNA prepared l)y hybridization to hydrops fetalis mRNA and by electrophoresis are comparable. In the present study, a similar procedure has been uised to isolate y cDNA from cord blood bv hybridizing total cord cDNA to nornmal adult reticulocyte mRNA containing negligible amounts of y mRNA. The single-stranded cDNA recovered has been used as purified y cDNA. The specificity of the y cDNA has been demonstrated by its complete hybridization at relatively low Cot values to a variety of mRNAs obtained from both adult and fetal cells known to contain large amounts of functional y mRNA. The complete hybridization of the y cDNA to mRNA from a patient homozygous for 8f3-thalassemia and completely lacking functional or structurally intact 8 and /8 mRNA indicates less than 20% contamination of y cDNA with 8 or ,3 mRNA.
In addition, the relatively similar Cot values at which 'y and a cDNAs are hybridized with 8So mRNA, and its lack of hybridization to fibroblast RNA make it extremely unlikely that the y cDNA is due to "nonglobin cDNA" resulting from nonglobin mRNA in the cord blood mRNA used to prepare the y cDNA. If the ,80 thalassemia spleen-1 ( ,8+ thalassemia spleen-1 ( y cDNA was primarily nonglobin eDNA specifically present in cord blood cells, the nonglobin mRNA it represented would not be present in amounts comparable to that of a mRNA in the cells of an adult patient with 8/8-thalassemia. Similarly, it should not be present in large amounts in the cells of adult patients with 8-thalassemia (Fig. 4, Table I ). With these considerations, the y cDNA is approximately 80% purified y cDNA. The high Cjt values required to fully hybridize the y cDNA to normal reticulocyte mRNA and hemoglobin H mRNA is additional evidence that the y cDNA is primarily y cDNA.
The lack of significant cross-hybridization of y cDNA with ,B mRNA sequences under the conditions used is quite remarkable, since the amino acid sequence of y and ,8 chains differ by only 38 of 146 amino acids (18) . Thus, it appears that there are more mutations in the nucleotide sequence coding for these globin genes than are reflected by changes in the amino acid sequence of y-and /3-globin. The nucleotide changes are apparently numerous enough to prevent stable hybrids between -y and 8 nucleotide sequences. It is possible that y cDNA sequences homologous to a and /8 mRNA exist but have been removed by our method of preparing y cDNA. However, the specificity of the y cDNA isolated suggests that such sequences do not exist in the cDNA we have obtained, which contains about 500 nucleotides. The results also indicate that the amount of y mRNA present in globin mRNA from human cells is roughly proportional to the relative amount ofy-globin translated in both intact cells and by mRNA in cell-free systems (Table I) .
With purified a-and /-globin cDNA, it has been possible to quantitate the relative numbers of a-and ,3-globin genes in normal and,-thalassemia cellular DNA. With these probes, it has been possible to demonstrate specific deletions of either a-or /8-like globin gene material in a-and 8/3-thalassemia (4, (6) (7) (8) and in hereditary persistence of fetal hemoglobin (8) (9) (10) . Similar results have been obtained with measurements of Cjt kinetics in cellular DNA excess (6, 7, 9, 10) and by limited cDNA excess hybridization (4, 8) . We prefer this latter method, which relies on the saturation plateaus obtained, since it requires less cellular DNA and is quite reproducible (3, 4, 8; Table II) .
In this paper, we have used the y cDNA probe to compare the amount of y-globin DNA in thalassemia and nonthalassemia DNA. The number of y-globin genes in cellular DNA from patients with ,8-thalassemia is similar to those in nonthalassemia DNA (Table II) .
Comparable numbers of a-and /8-globin genes have been previously reported in /+-thalassemia DNA as in nonthalassemia DNA (3, 4) . In the studies reported here, both ,+-and g'-thalassemia DNA were used and shown to contain y-globin genes in amounts comparable to normal DNA. These results indicate that there is no detectable deletion of structural y-globin genes in the DNA of these patients. On the basis of its size, the y cDNA represents about 500 nucleotides homologous to the y mRNA and starting at the 3' end of the RNA (Table  II) . All of the results are consistent with the two to four 'y globin genes per haploid genome, estimated from genetic data utilizing the relative amounts of .yGIY and yala in human subjects (19) .
Since this work was completed, y-globin gene measurements similar to ours have been reported with hybridization in a vast excess of cDNA (20) . In this report (20) , the authors state that there is less variability in gene numbers and greater sensitivity with a vast excess of cDNA. However, these same authors were unable to detect a deletion of (3-like globin genes in a heterozygote for 8,8-thalassemia with excess cDNA hybridization (5), while we have been able to do so easily using the methodology described in this paper (8) .
